For example, studies in pancreatic cancer identified a slow-cycling population, enriched for the CSC markers CD24+/CD44+, CD133+ and ALDH, which also had enhanced chemotherapeutic resistance and could recreate the initial heterogeneous tumor cell population 18. The gene discussed is CD24; the disease is neoplasm.